Relyea Zuckerberg Hanson’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-10,256	Closed	-$295K	–	237
2024 Q1	$295K	Sell	10,256 -1,405	-12%	-$42.3K	0.05%	184
2023 Q4	$383K	Buy	11,661 +1,220	+12%	+$33.2K	0.07%	139
2023 Q3	$291K	Buy	10,441 +762	+8%	+$24.9K	0.07%	150
2023 Q2	$330K	Sell	9,679 -1,808	-16%	-$56.8K	0.07%	138
2023 Q1	$345K	Hold	11,487	–	–	0.08%	125
2022 Q4	$324K	Buy	+11,487	New	+$365K	0.09%	126
2022 Q2	–	Sell	-6,619	Closed	-$292K	–	142
2022 Q1	$292K	Sell	6,619 -6,683	-50%	-$319K	0.1%	131
2021 Q4	$620K	Buy	13,302 +2,988	+29%	+$207K	0.22%	78
2021 Q3	$771K	Sell	10,314 -6,098	-37%	-$512K	0.3%	55
2021 Q2	$1.52M	Buy	16,412 +222	+1%	+$18.9K	0.62%	29
2021 Q1	$1.49M	Buy	16,190 +4,068	+34%	+$404K	0.66%	28
2020 Q4	$1.13M	Buy	12,122 +2,228	+23%	+$178K	0.61%	32
2020 Q3	$721K	Buy	9,894 +823	+9%	+$48.2K	0.46%	42
2020 Q2	$473K	Buy	9,071 +235	+3%	+$10.1K	0.38%	59
2020 Q1	$276K	Hold	8,836	–	–	0.3%	79
2019 Q4	$296K	Buy	+8,836	New	+$281K	0.28%	84